Group One Trading’s Repros Therapeutics Inc. RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-24,735
Closed -$16K 5767
2017
Q4
$16K Buy
+24,735
New +$12.5K ﹤0.01% 4242
2016
Q2
Sell
-4,064
Closed -$7.8K 5409
2016
Q1
$4K Buy
+4,064
New +$3.96K ﹤0.01% 4288

Group One Trading's RPRX Position: Q1 2018 in Review

Group One Trading sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 24,735 shares — an estimated $16K sold.

Group One Trading first reported a position in RPRX in Q1 2016 and held it in 2 quarters. The position peaked at $16K in Q4 2017. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.

  • Group One Trading reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
  • Group One Trading sold 24,735 Repros Therapeutics Inc. shares in Q1 2018, an estimated $16K.
  • Group One Trading first reported a position in Repros Therapeutics Inc. in Q1 2016 and held it in 2 quarters.
  • Group One Trading's Repros Therapeutics Inc. position peaked at $16K in Q4 2017.
  • 1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.

Based on Group One Trading's 13F filing for Q1 2018, filed 11 May 2018.